Trial intelligence / Profile preview

Topical 5% azelaic acid vs 2% minoxidil solution in female androgenetic alopecia

TCTR20180319001Phase 3Recruiting

Sponsor
Institutional review and signing
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Azelaic acid, minoxidil in androgenetic alopecia (AGA), sponsored by Institutional review and signing. Started Mar 2018; status: recruiting.

02

Drugs

Azelaic acidminoxidil
03

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on TCTR20180319001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180319001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call